TY  - GEN
AU  - Ribrag,V
AU  - Nasr,F
AU  - Bouhris,J H
AU  - Bosq,J
AU  - Brault,P
AU  - Girinsky,T
AU  - Cosset,J M
AU  - Munck,J N
AU  - Corti,C
AU  - Decaudin,D
AU  - Pico,J L
AU  - Hayat,M
AU  - Carde,P
TI  - VIP (etoposide, ifosfamide and cisplatinum) as a salvage intensification program in relapsed or refractory Hodgkin's disease
SN  - 0268-3369
PY  - 1998///0806
KW  - Adolescent
KW  - Adult
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Cisplatin
KW  - administration & dosage
KW  - Disease-Free Survival
KW  - Etoposide
KW  - Female
KW  - Hodgkin Disease
KW  - drug therapy
KW  - Humans
KW  - Ifosfamide
KW  - Male
KW  - Middle Aged
KW  - Prognosis
KW  - Recurrence
KW  - Salvage Therapy
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article
UR  - https://doi.org/10.1038/sj.bmt.1701202
ER  -